Orchard: A Biomarker-Directed Phase 2 Platform Study In Pts With Advanced Egfrm Nsclc Progressing On First-Line Osimertinib
JOURNAL OF THORACIC ONCOLOGY(2021)
Key words
osimertinib, non-small cell lung cancer, resistance
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined